共 14 条
[1]
Insights on 21 Years of HBV Surveillance in Blood Donors in France
[J].
VIRUSES-BASEL,
2022, 14 (11)
[2]
Re-Entry Evaluation of Chinese Blood Donors with Unconfirmed Hepatitis B Screening Results
[J].
VIRUSES-BASEL,
2022, 14 (11)
[3]
Lessons Learned from the COVID-19 Pandemic and How Blood Operators Can Prepare for the Next Pandemic
[J].
VIRUSES-BASEL,
2022, 14 (10)
[4]
An Outbreak of Japanese Encephalitis Virus in Australia; What Is the Risk to Blood Safety?
[J].
VIRUSES-BASEL,
2022, 14 (09)
[5]
Human Intramuscular Hyperimmune Gamma Globulin (hIHGG) Anti-SARS-CoV-2-Characteristics of Intermediates and Final Product
[J].
VIRUSES-BASEL,
2022, 14 (06)
[6]
Efficacy of Different Testing Scenarios in Reducing Transfusion-Transmitted Hepatitis B Virus (TT-HBV) Infection Risk
[J].
VIRUSES-BASEL,
2022, 14 (10)
[7]
Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and Treponema pallidum
[J].
VIRUSES-BASEL,
2022, 14 (12)
[8]
SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron
[J].
VIRUSES-BASEL,
2022, 14 (11)
[9]
HTLV-1/2 Infection in Blood Donors from a Non-Endemic Area (Catalonia, Spain) between 2008 and 2017: A 10-Year Experience
[J].
VIRUSES-BASEL,
2022, 14 (09)
[10]
Viral Metagenomics for Identification of Emerging Viruses in Transfusion Medicine
[J].
VIRUSES-BASEL,
2022, 14 (11)